Published: Thu, February 15, 2018
Research | By Jody Lindsey

SunTrust Banks Comments on Clovis Oncology Inc's Q3 2018 Earnings (CLVS)

Dekabank Deutsche Girozentrale stated it has 47,800 shares or 0.03% of all its holdings. After $-1.24 actual EPS reported by Clovis Oncology, Inc. for the previous quarter, Wall Street now forecasts 2.42% negative EPS growth.

South Street Advisors Llc, which manages about $326.54M and $515.73M US Long portfolio, decreased its stake in Cinemark Holding Inc (NYSE:CNK) by 9,850 shares to 45,080 shares, valued at $1.63M in 2017Q3, according to the filing. Tiffany & Co. (NYSE:TIF) has risen 46.84% since February 15, 2017 and is uptrending. It has outperformed by 42.32% the S&P500.The move comes after 8 months positive chart setup for the $3.12B company.

Christopher Medlock James decreased its stake in Clovis Oncology Inc (CLVS) by 40.43% based on its latest 2017Q3 regulatory filing with the SEC. Cypress Capital Management LLC WY increased its stake in shares of Clovis Oncology by 272.7% in the third quarter. The Artal Group Sa holds 115,000 shares with $9.48 million value, up from 25,000 last quarter. South Street Advisors Llc who had been investing in Visa Inc for a number of months, seems to be bullish on the $2.74 billion market cap company. Insiders sold 18,000 shares of company stock valued at $1,123,425 in the last quarter.

ILLEGAL ACTIVITY NOTICE: "SunTrust Banks Comments on Clovis Oncology Inc's Q3 2018 Earnings (CLVS)" was published by Week Herald and is owned by of Week Herald. It has outperformed by 30.14% the S&P500.

Investors sentiment increased to 1.35 in 2017 Q3. Its up 0.81, from 1.45 in 2017Q2. It turned negative, as 43 investors sold CVX shares while 696 reduced holdings. 16 funds opened positions while 65 raised stakes. It also increased its holding in Box Inc by 1.64 million shares in the quarter, for a total of 2.90 million shares, and has risen its stake in Edwards Lifesciences Corp (NYSE:EW). The California-based Stepstone Gp Lp has invested 0.06% in Xerium Technologies, Inc. (NYSE:ENV). Hutchin Hill Lp, a New York-based fund reported 15,200 shares. Jacobs Levy Equity Mgmt has 11,678 shares. Focused Wealth Management invested in 0.03% or 1,100 shares. Tiaa Cref Lc holds 333,006 shares or 0% of its portfolio. J.P. Morgan maintained Clovis Oncology, Inc. Janney Montgomery Scott Limited Liability Company has 7,745 shares for 0.01% of their portfolio. (NYSE:ENV) for 372,900 shares. (NYSE:ENV). Arrowmark Colorado Limited Liability Co holds 0.23% or 396,434 shares.

Freeport-McMoRan Inc. (FCX) : Investors need to focus on Analysts Rating
Volume gives an investor an inspiration of the price action of a security and whether he should buy or sell the security. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.

Among 20 analysts covering Clovis Oncology (NASDAQ:CLVS), 14 have Buy rating, 0 Sell and 6 Hold. Therefore 54% are positive. Envestnet had 27 analyst reports since August 11, 2015 according to SRatingsIntel. (NYSE:ENV) on Thursday, June 2 to "Buy" rating. The firm has "Hold" rating by SBG Securities given on Thursday, November 30. Stifel Nicolaus maintained the stock with "Buy" rating in Monday, January 23 report. The firm has "Buy" rating by Suntrust Robinson given on Wednesday, August 24. RBC Capital Markets maintained Clovis Oncology, Inc. WallachBeth Capital downgraded it to "Hold" rating and $30 target in Tuesday, November 17 report. The firm has "Neutral" rating given on Friday, March 18 by Nomura. Bank of America initiated it with "Buy" rating and $74 target in Friday, January 27 report. The firm has "Sector Perform" rating by RBC Capital Markets given on Friday, September 25. The insider CROWELL GAYLE A sold $33,160. Arora Anil had sold 10,000 shares worth $538,815 on Thursday, January 11. Shares for $2.30 million were sold by Zapolsky David on Tuesday, August 15. $1.96M worth of, Inc. Phocas Financial Corp. purchased a new position in shares of Clovis Oncology in the second quarter worth about $112,000. The company has market cap of $1.18 billion. Yodlee business divisions. It now has negative earnings.

Since August 15, 2017, it had 0 insider purchases, and 5 sales for $1.12 million activity. IVERS-READ GILLIAN C also sold $192,480 worth of Clovis Oncology, Inc. (NASDAQ:CLVS) on Monday, January 8. (NASDAQ:AMZN) shares were sold by Jassy Andrew R. Shares for $2.31M were sold by Olsavsky Brian T. Its up 0.02, from 1.33 in 2017Q2. It fall, as 48 investors sold CLVS shares while 49 reduced holdings. 42 funds opened positions while 98 raised stakes. Jefferies Group Inc Inc Ltd Liability Corp has invested 0.01% in Clovis Oncology, Inc. (NASDAQ:CLVS) for 21,002 shares. Nationwide Fund accumulated 54,080 shares or 0% of the stock. Moreover, Alpha Windward Ltd Liability has 0.19% invested in Chevron Corporation (NYSE:CVX). (NASDAQ:CLVS) rating on Monday, September 18. (NASDAQ:IRDM). First Lp accumulated 183,764 shares. Moreover, Guggenheim has 0.01% invested in Clovis Oncology, Inc. (NASDAQ:CLVS) or 51,700 shares. The stock of Clovis Oncology, Inc. (NASDAQ:CLVS). 5,038 are owned by Great West Life Assurance Can. Lsv Asset Management holds 0% or 74,000 shares in its portfolio. Following the completion of the transaction, the director now owns 21,118 shares of the company's stock, valued at approximately $1,372,036.46. Cypress Mgmt Ltd Company (Wy) reported 0.2% of its portfolio in Clovis Oncology, Inc. Sei has invested 0% of its portfolio in Vector Group Ltd. (NYSE:VGR). (NASDAQ:CLVS) for 2,233 shares.

Clovis Oncology (NASDAQ:CLVS) last released its quarterly earnings results on Wednesday, November 1st. (NASDAQ:CLVS) or 12,859 shares. (NASDAQ:CLVS). Nuveen Asset Management Ltd Liability holds 0.01% in Clovis Oncology, Inc. 413 are owned by Us Commercial Bank De.

Jane Street Group Llc increased Hrg Group Inc (NYSE:HRG) stake by 450,816 shares to 898,656 valued at $14.03 million in 2017Q3. Ishares Inc (SCJ) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this: